Table 2 Clinical outcome of infection versus control group.

From: Impact of infection-related admission in patients with heart failure: a 10 years national cohort study

 

Total (N = 31,318)

Control (Ref.) (N = 15,659)

Infection (N = 15,659)

Crude HR (95% CI)

p value

Adjusted HR (95% CI)

p value

Primary composite endpoint

23,460 (74.91)

9964 (63.63)

13,496 (86.19)

1.885 (1.837–1.935)

< 0.001

1.760 (1.714–1.807)

< 0.001

Mortality

18,053 (57.64)

7180 (45.85)

10,873 (69.44)

1.796 (1.743–1.851)

< 0.001

1.587 (1.540–1.636)

< 0.001

HHF

12,773 (40.78)

4996 (31.90)

7777 (49.66)

2.054 (1.981–2.128)

< 0.001

1.993 (1.922–2.066)

< 0.001

MI

2244 (7.17)

1000 (6.39)

1244 (7.94)

1.470 (1.352–1.598)

< 0.001

1.332 (1.224–1.450)

< 0.001

Ischemic stroke

4353 (13.90)

1746 (11.15)

2607 (16.65)

1.872 (1.761–1.989)

< 0.001

1.769 (1.664–1.882)

< 0.001

  1. Model was adjusted for age, sex, comorbidities, procedure history, medication history.
  2. HR hazard ratio, HHF hospitalization for heart failure, MI myocardial infarction.
Back to article page